Junji Hiraga

720 total citations
17 papers, 464 citations indexed

About

Junji Hiraga is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Junji Hiraga has authored 17 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 5 papers in Molecular Biology. Recurrent topics in Junji Hiraga's work include Lymphoma Diagnosis and Treatment (10 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). Junji Hiraga is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). Junji Hiraga collaborates with scholars based in Japan. Junji Hiraga's co-authors include Tomohiro Kinoshita, Tomoki Naoe, Akihiro Tomita, Hitoshi Kiyoi, Shigeo Nakamura, Takumi Sugimoto, Masafumi Ito, Kazuyuki Shimada, Masayuki Kimura and Takuhei Murase and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Junji Hiraga

16 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junji Hiraga Japan 8 266 185 142 119 102 17 464
Guido Parvis Italy 13 241 0.9× 197 1.1× 152 1.1× 113 0.9× 56 0.5× 27 437
Sabela Bobillo Spain 11 271 1.0× 206 1.1× 121 0.9× 64 0.5× 64 0.6× 39 437
Vera Vanhentenrijk Belgium 12 374 1.4× 241 1.3× 219 1.5× 144 1.2× 143 1.4× 13 571
Julia Steinhilber Germany 15 392 1.5× 260 1.4× 235 1.7× 144 1.2× 132 1.3× 28 652
Vaishalee P. Kenkre United States 13 258 1.0× 260 1.4× 208 1.5× 73 0.6× 120 1.2× 37 456
JL Huret France 6 301 1.1× 166 0.9× 128 0.9× 126 1.1× 91 0.9× 100 521
Naohiro Sekiguchi Japan 12 400 1.5× 254 1.4× 209 1.5× 86 0.7× 102 1.0× 61 570
K. Adams United Kingdom 6 326 1.2× 261 1.4× 135 1.0× 56 0.5× 80 0.8× 8 520
Noraidah Masir Malaysia 12 205 0.8× 163 0.9× 101 0.7× 90 0.8× 77 0.8× 48 396
Andrea Guffanti Italy 11 214 0.8× 105 0.6× 185 1.3× 95 0.8× 68 0.7× 20 409

Countries citing papers authored by Junji Hiraga

Since Specialization
Citations

This map shows the geographic impact of Junji Hiraga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Hiraga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Hiraga more than expected).

Fields of papers citing papers by Junji Hiraga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Hiraga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Hiraga. The network helps show where Junji Hiraga may publish in the future.

Co-authorship network of co-authors of Junji Hiraga

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Hiraga. A scholar is included among the top collaborators of Junji Hiraga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Hiraga. Junji Hiraga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
Hiraga, Junji, et al.. (2018). Composite Lymphoma Comprising Extranodal NK/T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma. SHILAP Revista de lepidopterología. 2018. 1–4. 1 indexed citations
4.
Hiraga, Junji, Yusuke Takagi, Haruhiko Ohashi, et al.. (2017). A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag. International Journal of Hematology. 108(1). 109–111. 17 indexed citations
5.
6.
7.
Tokunaga, Takashi, Akihiro Tomita, Kazuyuki Shimada, et al.. (2010). Discrepancy of CD20 Protein Expression In IHC and FCM Analyses In Primary B-Cell Lymphoma: Relationship Between FCM-Negative Phenotype and Rituximab Binding with Lymphoma Cells. Blood. 116(21). 5087–5087. 1 indexed citations
8.
Hiraga, Junji, Akihiro Tomita, Takumi Sugimoto, et al.. (2009). Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance. Blood. 113(20). 4885–4893. 194 indexed citations
9.
Sugimoto, Takumi, Akihiro Tomita, Junji Hiraga, et al.. (2009). Escape mechanisms from antibody therapy to lymphoma cells: Downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation. Biochemical and Biophysical Research Communications. 390(1). 48–53. 35 indexed citations
10.
11.
Xu, Jinglan, Junji Hiraga, Tetsuro Nagasaka, et al.. (2008). Clinical significance of nuclear non‐phosphorylated beta‐catenin in acute myeloid leukaemia and myelodysplastic syndrome. British Journal of Haematology. 140(4). 394–401. 38 indexed citations
12.
Sugimoto, Takumi, Akihiro Tomita, Kazuyuki Shimada, et al.. (2008). Relationship Between Post-Translational Modification of CD20 Protein and the Responsiveness to Rituximab Treatment. Blood. 112(11). 2667–2667. 1 indexed citations
13.
Tomita, Akihiro, Junji Hiraga, Hitoshi Kiyoi, et al.. (2007). Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy. International Journal of Hematology. 86(1). 49–57. 41 indexed citations
14.
Tomita, Akihiro, Junji Hiraga, Hitoshi Kiyoi, Tomohiro Kinoshita, & Tomoki Naoe. (2007). Epigenetic Regulation of CD20 Protein Expression in B-Cell Lymphoma Cells after Rituximab-Containing Chemotherapy.. Blood. 110(11). 3423–3423. 1 indexed citations
15.
Hiraga, Junji, Tomohiro Kinoshita, Naoyoshi Mori, et al.. (2006). Promoter Hypermethylation of the DNA-Repair Gene O 6 -Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma. International Journal of Hematology. 84(3). 248–255. 20 indexed citations
16.
Hiraga, Junji, Haruhiko Ohashi, Haruhiko Asano, et al.. (2006). Loss of O 6 -Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma. International Journal of Hematology. 83(4). 341–347. 25 indexed citations
17.
Murase, Takuhei, Shigeo Nakamura, Kazuhiro Tashiro, et al.. (1997). Malignant histiocytosis‐like B‐cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature. British Journal of Haematology. 99(3). 656–664. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guido Parvis Breakdown of academic impact, for papers by Sabela Bobillo Breakdown of academic impact, for papers by Vera Vanhentenrijk Breakdown of academic impact, for papers by Julia Steinhilber Breakdown of academic impact, for papers by Vaishalee P. Kenkre Breakdown of academic impact, for papers by JL Huret Breakdown of academic impact, for papers by Naohiro Sekiguchi Breakdown of academic impact, for papers by K. Adams Breakdown of academic impact, for papers by Noraidah Masir Breakdown of academic impact, for papers by Andrea Guffanti
Rankless by CCL
2026